Gloperba (Colchicine) Patent Expiration, LOE Window & CMS Spending
Gloperba (Colchicine) by Scilex: FDA Orange Book LOE 2037-12-20, 17 AB generics, $60K 2024 CMS Part D & Medicaid spend.
| Regulatory & Reimbursement Dimension | Verified Value |
|---|---|
| Consolidated Sponsor | Scilex |
| FDA Application & Pathway | N210942 (NDA) |
| Exclusivity / Cliff Horizon | Long-Dated Protection (2036+) |
| Core Active-Ingredient LOE Date | Not listed / N/A |
| Last Listed Patent or Exclusivity Date | 2037-12-20 |
| Orange Book Patents (*PED Extensions) | 6 patents (0 *PED) |
| Active AB-Rated Generic Competitors | 17 |
| 2024 CMS Total Public Spend | $60K |
| 2024 Medicare Part D Spend | $33K |
| 2024 Medicaid Spend | $27K |
| Reported Wholesale Price Change (CA SB 17) | 0 statutory filings in 2023 to 2026 panel |